About Medisync Healthcare
Healthcare / Diagnostics
Medisync Healthcare operates a chain of diagnostic centers across Tier-2 and Tier-3 cities in North India. The company offers pathology, radiology, and preventive health checkup services.
MH
Medisync Healthcare IPO
GMP, Subscription, Price, Allotment, Listing Date & AI Prediction
closed
BSE SME
GMP is +Rs 18 (+18.4%), issue size is Rs 28.4 Cr Cr, subscription is 112.5x, and allotment is on 10 Mar 2026.
PRICE BAND
Rs 92 - 98
LOT SIZE
1,200
Shares
MIN INVEST
Rs 1.2L
CUT-OFF
Rs 98
per share
Open
03 Mar 2026
Last Day
07 Mar 2026
Allotment
10 Mar 2026
Expected Refund
11 Mar 2026
Listing
12 Mar 2026
Final Subscription
Final subscription snapshot
Final subscription data is being compiled.
Current IPO Status: closed
Issue Details
Total Issue Size
Rs 28 Cr
Issue Size for Retail
Rs 9.94 Cr
Fresh Issue vs OFS
Fresh Issue
Rs 28.4 Cr (100%)Reservation Quota
QIB
50%
Retail
35%
NII
15%
Lead Manager
Unistone Capital
Registrar
Bigshare Services
Objects of the Issue (as per DRHP)
- 1Opening 15 new diagnostic centers
- 2Purchase of advanced diagnostic equipment
- 3Technology upgradation for LIMS
- 4Working capital requirements
Medisync Healthcare Financials
| Metric | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | 32.5Rs 32.5 Cr | 42.8Rs 42.8 Cr | 55.2Rs 55.2 Cr | 55.2Rs 55.2 Cr |
| Net Profit (PAT) | 3.2Rs 3.2 Cr | 4.5Rs 4.5 Cr | 6.1Rs 6.1 Cr | 6.1Rs 6.1 Cr |
| EBITDA | 5.4Rs 5.4 Cr | 7.2Rs 7.2 Cr | 9.8Rs 9.8 Cr | 9.8Rs 9.8 Cr |
| Borrowings | - | - | - | - |
| ROE | 24.5%24.5% | 24.5%24.5% | 24.5%24.5% | 24.5%24.5% |
| ROCE | 21.2%21.2% | 21.2%21.2% | 21.2%21.2% | 21.2%21.2% |
| Debt/Equity | 0.280.28 | 0.280.28 | 0.280.28 | 0.280.28 |
| Assets | - | - | - | - |
Company Financials
Financial charts load as you reach this section.
MARKET SENTIMENT SCORE
0
50
100
72
Bullish
Based on expert reviews, GMP trends & market signals
Expert Reviews & Opinions
Expert reviews for Medisync Healthcare IPO will appear here once available.
Reviews are summarized from YouTubers, analysts, news channels, and brokerage firms using AI.
Peer Comparison
Comparing with 2 listed peersIPO P/E Ratio
21.5x
vs Peer Avg: 62.3x
IPO Market Cap
~115 Cr
Peer Avg: 18K Cr
IPO ROE
24.5%
vs Peer Avg: 20.4%
| Company | Market Cap | Revenue | PAT | P/E | ROE |
|---|---|---|---|---|---|
MH Medisync HealthcareIPO | ~115 Cr | Rs 55.2 Cr | Rs 6.1 Cr | 21.5x | 24.5% |
| Dr Lal PathLabs | 23K Cr | 2.4K Cr | 385 Cr | 58.4x | 22.5% |
| Metropolis Healthcare | 14K Cr | 1.4K Cr | 215 Cr | 66.1x | 18.2% |
| Peer Average | 18K Cr | 1.9K Cr | 300 Cr | 62.3x | 20.4% |
Quick Analysis
- Medisync Healthcare's P/E of 21.5x is lower than the peer average of 62.3x, suggesting relatively attractive valuation.
- ROE of 24.5% is above peer average (20.4%), indicating better return on equity.
- Market cap post-listing would place Medisync Healthcare below peer average in terms of size.
* All peer data is from publicly available sources. Financial figures are latest reported annual numbers.
Grey Market Premium
Medisync Healthcare IPO GMP Today
GMP trend chart and full day-by-day history
Subscription Status
Medisync Healthcare IPO Subscription
Live status, allotment chance and day-wise figures
Frequently Asked Questions
What is the price band of Medisync Healthcare IPO?
The price band is Rs 92-98 per share. One lot contains 1200 shares; its value at the upper price is Rs 1,17,600. Check the issue terms for the minimum application size applicable to your category.
What are the bidding dates for Medisync Healthcare IPO?
The scheduled bidding period is 3 Mar 2026 to 7 Mar 2026.
When is Medisync Healthcare IPO scheduled to list?
The scheduled listing date is 12 Mar 2026. The actual listing price is determined on the exchange, not by the grey market premium or an AI estimate.
Who is the registrar for Medisync Healthcare IPO?
Bigshare Services is the registrar. See the allotment page for the available schedule and official checking link.
Who manages Medisync Healthcare IPO?
Lead manager information recorded for this issue: Unistone Capital.
Disclaimer
IPOGyani is not SEBI registered and does not provide investment advice. All information is for educational purposes only.
AI predictions are probabilistic estimates based on historical data and market trends. Past performance is not indicative of future results.
GMP (Grey Market Premium) data is sourced from various unofficial channels and may not be accurate. Always verify from multiple sources.
Investors should do their own research (DYOR) and consult a SEBI registered advisor before investing.
Current IPO Pages
Explore detailed GMP, subscription and IPO analysis pages for the latest active issues.